Recent 8-K filings for ACU
Highest-materiality recent filing
Acme United Q1 diluted EPS up 39% to $0.39; gross margin expands to 38.7%
- Net sales $45.0M, down 2% YoY; ex-divested lines up 1%. Net income $1.6M, up 65%.
- Diluted EPS $0.39 vs $0.28, a 39% increase. Gross margin 38.7% vs 35.5%.
-
Acme United Q2 net sales up 16% to $62.7M; EPS rises to $1.22 from $1.16
Q2 net sales $62.7M (+16% YoY); organic growth 8% excluding My Medic acquisition.
-
Acme United enters $65M syndicated credit facility with HSBC and City National Bank, maturing 2029
New $65M revolving credit facility replaces prior HSBC facility; matures July 15, 2029.
-
ACME UNITED Corporation Reports Results of 2026 Annual Meeting of Shareholders
All seven director nominees elected: Walter C. Johnsen, Richmond Y. Holden, Brian S. Olschan, Susan H. Murphy, Rex L. Davidson, Brian K. Barker, Paul J. Conway.
-
Acme United Q1 sales up 14% to $52.3M; net income down 40% to $1.0M on tariff costs
Net income $1.0M ($0.24 diluted EPS) vs $1.7M ($0.41) YoY, down 40% and 41% respectively.
-
Acme United Q4 EPS $0.46 (+12% YoY); revenue $47.5M (+3%); acquires My Medic for $18.7M
Q4 net income $1.9M ($0.46 diluted EPS) vs $1.7M ($0.41 EPS) YoY, a 12% increase.
-
Acme United acquires assets of My Medic for $18.7M; My Medic had $19M revenue in 2025
Paid $14.6M cash at closing; up to $4.1M additional based on 2027 revenue milestones and indemnification holdback.
-
Acme United Q3 net sales up 2% to $49.1M; EPS falls 15% to $0.46 on higher tax rate
Net sales $49.1M (+2% YoY); net income $1.9M vs $2.2M (-14%); diluted EPS $0.46 vs $0.54 (-15%).
-
Acme United reports record Q2 net income of $4.8M; sales down 3% to $54.0M
Q2 net income $4.8M ($1.16 diluted EPS), up 7% YoY; record quarterly net income.
-
Acme United extends $65M revolver maturity to May 31, 2027
Amendment No. 11 to Loan Agreement extends maturity of $65M secured revolving credit facility from May 2026 to May 31, 2027.
-
ACME United shareholders reelect all director nominees at 2025 annual meeting
All seven director nominees elected with 2.58M-2.69M votes for each.
-
Acme United Q1 EPS rises 5% to $0.41; net sales up 2% to $46.0M
EPS $0.41 vs $0.39 (+5%); net income $1.65M vs $1.64M (+1%).
-
Acme United replaces auditor Marcum with CBIZ after Marcum's resignation due to acquisition
Marcum LLP resigned as independent auditor on March 24, 2025, following acquisition of its attest business by CBIZ.
-
Acme United Q4 net sales up 10% to $45.9M; FY adj. net income up 23%
Q4 net sales $45.9M (+10% YoY); FY net sales $194.5M (+2% YoY, +6% ex-Camillus/Cuda).
-
Acme United Q3 net income rises 3% to $2.23M despite 4% sales decline
Net income $2.23M ($0.54/diluted) vs $2.15M ($0.58) in Q3 2023; net income up 3%, EPS down 7%.
-
Acme United Q2 net income +29% to $4.5M; acquires Elite First Aid
Q2 net sales $55.4M (+4% YoY; +8% excl. divested Camillus/Cuda lines).
-
Acme United Q2 net income up 29% to $4.5M; EPS $1.09 vs $0.96; revenue $55.4M +4%
Q2 net sales $55.4M (+4% YoY); excluding divested hunting/fishing lines, organic growth 8%.
-
ACME United shareholders re-elect all directors and approve all proposals at annual meeting
Walter C. Johnsen re-elected with 2,284,155 votes for, 17,677 withheld.
-
Acme United Q1 diluted EPS up 39% to $0.39; gross margin expands to 38.7%
Net sales $45.0M, down 2% YoY; ex-divested lines up 1%. Net income $1.6M, up 65%.
-
Acme United amends bylaws to permit remote and hybrid shareholder meetings
Board approved amendment to Article 2, Section 3 of Bylaws effective March 28, 2024.
-
Acme United Q4/FY2023: adjusted EPS $2.23 vs $0.82; gross margin 37.7%; debt down $19M
Full year 2023 net sales $191.5M (-1% YoY); Q4 net sales $41.9M (-5% YoY, -1% ex-divestiture).
-
Acme United sells Camillus and Cuda product lines to GSM Holdings for $19.8M
Sale price of $19.773M; after-tax gain of ~$10.0M expected in Q4 2023.
-
Acme United Q3 record EPS $0.58 vs $0.02 YoY; sales up 1% to $50.4M
Net income $2.2M ($0.58 diluted EPS) vs $64K ($0.02) in Q3 2022; nine-month EPS $1.83, up 91%.
-
Acme United Q2 EPS rises 35% to $0.96, net income $3.4M; gross margin up 480 bps
Q2 net sales $53.3M (-6% YoY); net income $3.4M (+26%); diluted EPS $0.96 (+35%).
-
All seven director nominees elected with votes ranging from 1.83M to 2.57M; no withhold majority.
-
Acme United Q1 2023 sales up 6% to $45.8M; diluted EPS $0.28 (+27% YoY)
Net income $990K vs $830K (+19%); operating income +60% on higher sales and gross margin.
-
Acme United Q4 net loss $0.17/share; full-year EPS $0.82 vs adjusted $2.57
Q4 net sales $44.1M, down 4% YoY; net loss $597K vs income $2.34M in prior year.
-
Acme United Q3 EPS plummets to $0.02 from $0.50 on supply chain costs; sales up 4%
Q3 net sales $49.7M (+4% YoY); net income $64,000 ($0.02 diluted EPS) vs $2.0M ($0.50) in Q3 2021.
-
Acme United Q2 sales up 27% to $56.8M; adjusted EPS flat at $0.71; acquires Safety Made for ~$11M
Net sales $56.8M (+27% YoY); adjusted EPS $0.71 (flat vs adj. $0.71 in Q2 2021); gross margin 33% vs 36%.
-
Acme United increases bank facility to $65M with HSBC, extends to May 2026
Facility increased by $15M to $65M; interest rate SOFR + 1.75%; maturity May 31, 2026.
-
Acme United acquires Safety Made assets for undisclosed sum; revenue $4.9M, EBITDA $1.2M
Purchased assets of Live Safely Products, LLC (Safety Made), a first aid kit manufacturer for promotional products.
-
Acme United shareholders reject amendment to Non-Salaried Director Stock Option Plan
Proposal 3 failed with 898,966 for, 1,026,903 against, 139,557 abstain.
-
Acme United Q1 net income falls 59% to $0.22 EPS; supply chain disruptions cited
Net sales $43.3M vs $43.5M; net income $830k ($0.22 diluted EPS) down 59% from $2.05M ($0.52) YoY.
-
Q4 net sales $45.8M (+12%); net income $2.34M ($0.60 diluted EPS) vs $2.04M ($0.54).
-
Acme United enters $11.6M fixed-rate mortgage with HSBC at 3.8%
Mortgage of $11.6M at 3.8% fixed rate, 7-year term, 20-year amortization.
-
Acme United establishes Rule 10b5-1 trading plan for stock repurchases over 12 months
Plan adopted November 12, 2021; part of existing stock repurchase programs.
-
Acme United Q3 2021 sales up 11% to $47.9M; net income up 30% to $2.05M
Diluted EPS $0.50 vs $0.46 YoY (+9%), nine-month EPS ex-PPP $1.97 vs $1.75.
-
Acme United Q2 net income up 16% to $3.7M; EPS $0.94, +2% YoY
Net sales Q2 2021 $44.8M, up 2% YoY; Europe +26%, Canada +68% in USD; U.S. down 4% due to warehouse system installation.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.80 · Median 0.65 · Most common event earnings